Anticancer drugs are considered pseudo-persistent pollutants for the water environmental compartments due to their continuous emission into water bodies. Many sources contribute to the bioaccumulation of the drugs, and the investigation of their residues and transformation products (TPs) fate is mandatory, in particular for compounds displaying a high degree of toxicity. Here, we present a High-Performance Liquid Chromatography – High-Resolution Mass Spectrometry (HPLC-HRMS) method developed to identify and characterize the TPs of cyclophosphamide (CYC), 5-fluorouracil (5FU) and oxaliplatin (OXA), subjected to heterogenous photocatalysis mediated by titanium dioxide. The irradiation experiments were performed at different times, and the HPLC separation was achieved using a reverse-phase column. A high-resolution Orbitrap mass analyzer was used in the positive and negative ionization modes with a resolution of 30k. Tandem mass spectrometry experiments were acquired in the CID activation mode. With the developed method, we recognized and tentatively assigned the structures of six TPs for CYC, four TPs for 5FU and one TPs for OXA. The developed analytical method was then applied to real environmental water samples coming from nine sampling sites of Po River (Italy). We found the presence of CYC in four site points at level of ppb. The developed HPLC-HRMS method was a satisfactory tool to identify anticancer drugs and their TPs and to quantify them in real water environmental samples.
NaiduRArias EspanaVALiuY,et al.Emerging contaminants in the environment: risk-based analysis for better management. Chemosphere2016; 154: 350–357.
2.
Ramírez-MaluleHQuiñones-MurilloDHManotas-DuqueD. Emerging contaminants as global environmental hazards. A bibliometric analysis. Emerg Contam2020; 6: 179–193.
3.
BookerVHalsallCLlewellynN, et al.Prioritising anticancer drugs for environmental monitoring and risk assessment purposes. Sci Total Environ2014; 473–474 159–170.
4.
ToolaramAPKümmererKSchneiderM. Environmental risk assessment of anti-cancer drugs and their transformation products: a focus on their genotoxicity characterization-state of knowledge and short comings. Mutat Res - Rev Mutat Res2014; 760: 18–35.
5.
JureczkoMKalkaJ. Cytostatic pharmaceuticals as water contaminants. Eur J Pharmacol2020; 866: 172816.
6.
CristóvãoMBJanssensRYadavA, et al.Predicted concentrations of anticancer drugs in the aquatic environment: what should we monitor and where should we treat?J Hazard Mater2020; 392: 122330.
7.
NassourCNabhani-GebaraSBartonSJ,et al.Aquatic ecotoxicology of anticancer drugs: a systematic review. Sci Total Environ2021; 800: 149598.
8.
GouveiaTIAMotaIHSilvaAMT, et al.Are cytostatic drugs in surface waters a potential threat?Sci Total Environ2022; 853: 158559.
9.
Ferrando-ClimentLRodriguez-MozazSBarcelóD. Incidence of anticancer drugs in an aquatic urban system: from hospital effluents through urban wastewater to natural environment. Environ Pollut2014; 193: 216–223.
10.
Gómez-CanelaCVenturaFCaixachJ,et al.Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry. Anal Bioanal Chem2014; 406: 3801–3814.
11.
RabiiFWSeguraPAFayadPB,et al.Determination of six chemotherapeutic agents in municipal wastewater using online solid-phase extraction coupled to liquid chromatography-tandem mass spectrometry. Sci Total Environ2014; 487: 792–800.
12.
AzumaTIshiuchiHInoyamaT, et al.Occurrence and fate of selected anticancer, antimicrobial, and psychotropic pharmaceuticals in an urban river in a subcatchment of the Yodo River basin. Japan. Environ Sci Pollut Res2015; 22: 18676–18686.
13.
IsidoriMLavorgnaMRussoC, et al.Chemical and toxicological characterisation of anticancer drugs in hospital and municipal wastewaters from Slovenia and Spain. Environ Pollut2016; 219: 275–287.
14.
SantosMSFFranquet-GriellHLacorteS, et al.Anticancer drugs in Portuguese surface waters – Estimation of concentrations and identification of potentially priority drugs. Chemosphere2017; 184: 1250–1260.
15.
OlallaANegreiraNLópez de AldaM, et al.A case study to identify priority cytostatic contaminants in hospital effluents. Chemosphere2018; 190: 417–430.
16.
SantosMSFFranquet-GriellHAlvesA,et al.Development of an analytical methodology for the analysis of priority cytostatics in water. Sci Total Environ2018; 645: 1264–1272.
17.
Castellano-HinojosaAGallardo-AltamiranoMJGonzález-LópezJ,et al.Anticancer drugs in wastewater and natural environments: A review on their occurrence, environmental persistence, treatment, and ecological risks. J Hazard Mater2023; 447: 130818.
18.
Martín-PozoLde Alarcón-GómezBRodríguez-GómezR, et al.Analytical methods for the determination of emerging contaminants in sewage sludge samples. A review. Talanta2019; 192: 508–533.
19.
OluwoleAOOmotolaEOOlatunjiOS. Pharmaceuticals and personal care products in water and wastewater: a review of treatment processes and use of photocatalyst immobilized on functionalized carbon in AOP degradation. BMC Chem2020; 14: 1–29.
20.
CalzaPMedanaCSarroM, et al.Photocatalytic degradation of selected anticancer drugs and identification of their transformation products in water by liquid chromatography-high resolution mass spectrometry. J Chromatogr A2014; 1362: 135–144.
21.
OfiarskaAPieczyńskaAFiszka BorzyszkowskaA, et al.Pt-TiO2-assisted photocatalytic degradation of the cytostatic drugs ifosfamide and cyclophosphamide under artificial sunlight. Chem Eng J2016; 285: 417–427.
22.
VelempiniTPrabakaranEPillayK. Recent developments in the use of metal oxides for photocatalytic degradation of pharmaceutical pollutants in water – a review. Mater Today Chem2021; 19: 100380.
23.
YangHLiGAnT, et al.Photocatalytic degradation kinetics and mechanism of environmental pharmaceuticals in aqueous suspension of TiO2: a case of sulfa drugs. Catal Today2010; 153: 200–207.
24.
BennemlaMBouafia-CherguiSAmraneA,et al.The photocatalytic degradation kinetics of the anti-inflammatory drug ibuprofen in aqueous solution under UV/TiO2 system and neural networks modeling. Int J Chem React Eng2022; 20: 1149–1161.
25.
BerberidouCKitsiouVLambropoulouDA, et al.Decomposition and detoxification of the insecticide thiacloprid by TiO2-mediated photocatalysis: kinetics, intermediate products and transformation pathways. J Chem Technol Biotechnol2019; 94: 2475–2486.
26.
CalzaPJiménez-HolgadoCCohaM, et al.Study of the photoinduced transformations of sertraline in aqueous media. Sci Total Environ2021; 756: 143805.
27.
GongHChuWHuangY, et al.Solar photocatalytic degradation of ibuprofen with a magnetic catalyst: effects of parameters, efficiency in effluent, mechanism and toxicity evolution. Environ Pollut2021; 276: 116691.
28.
Jiménez-HolgadoCCalzaPFabbriD, et al.Investigation of the aquatic photolytic and photocatalytic degradation of citalopram. Molecules2021; 26(17): 5331.
29.
Martínez BuenoMJAgüeraAGómezMJ, et al.Application of liquid chromatography/quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater. Anal Chem2007; 79: 9372–9384.
30.
TislerSZindlerFFreelingF, et al.Transformation products of fluoxetine formed by photodegradation in water and biodegradation in zebrafish embryos (Danio rerio). Environ Sci Technol2019; 53: 7400–7409.
31.
ScholléeJESchymanskiELAvakSE, et al.Prioritizing unknown transformation products from biologically-treated wastewater using high-resolution mass spectrometry, multivariate statistics, and metabolic logic. Anal Chem2015; 87: 12121–9.
32.
HuDWuJFanL, et al.Aerobic degradation characteristics and mechanism of decabromodiphenyl ether (BDE-209) using complex bacteria communities. Int J Environ Res Public Health2022; 19: 17012.
33.
GhattasAKFischerFWickA,et al.Anaerobic biodegradation of (emerging) organic contaminants in the aquatic environment. Water Res2017; 116: 268–295.
34.
LahtiMOikariA. Microbial transformation of pharmaceuticals naproxen, bisoprolol, and diclofenac in aerobic and anaerobic environments. Arch Environ Contam Toxicol2011; 61: 202–210.
35.
CalzaPMedanaCPadovanoE, et al.Identification of the unknown transformation products derived from lincomycin using LC-HRMS technique. J Mass Spectrom2012; 47: 751–759.
36.
MedanaCCalzaPDal BelloF,et al.LC–HRMS determination of anticancer drugs as occupational contaminants applied to photocatalytic degradation of molecules of different stability. Curr Trends Mass Spectrom2013(special issue): 30–37.
37.
ČesenMEleršekTNovakM, et al.Ecotoxicity and genotoxicity of cyclophospamide, ifosfamide, their metabolites/transformation products and their mixtures. Environ Pollut2016; 210: 192–201.
38.
Dal BelloFSantoroVScarpinoV, et al.Antineoplastic drugs determination by HPLC-HRMSn to monitor occupational exposure. Drug Test Anal2016; 8: 730–737.
39.
LutterbeckCAWildeMLBaginskaE, et al.Degradation of cyclophosphamide and 5-fluorouracil by UV and simulated sunlight treatments: assessment of the enhancement of the biodegradability and toxicity. Environ Pollut2016; 208: 467–476.
40.
EmadiAJonesRJBrodskyRA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol2009; 6: 638–647.
41.
ChengWBPChengYC. Metabolism and mechanism of action of 5-fluorodeoxycytidine. Proc Natl Acad Sci U S A1982; 79: 6419–6423.
42.
AndréTBoniCMounedji-BoudiafL, et al.Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med2004; 350: 2343–2351.
43.
StordalBPavlakisNDaveyR. Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treat Rev2007; 33: 347–357.
44.
SchymanskiELJeonJGuldeR, et al.Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol2014; 48: 2097–2098.
45.
Dal BelloFMecarelliEAigottiR, et al.Development and application of high resolution mass spectrometry analytical method to study and identify the photoinduced transformation products of environmental pollutants. J Environ Manage2022; 308: 114573.
46.
CzernychRHalkiewiczJKot-WasikA,et al.Development and validation of SPE-HPLC-MS/MS method for determining cyclophosphamide in surface waters. Pol J Environ Stud2014; 23: 1537–1545.
47.
KimMKLeeTHSuhJH, et al.Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma. J Chromatogr B Anal Technol Biomed Life Sci2010; 878: 2235–2242.
48.
Franquet-GriellHCornadóDCaixachJ, et al.Determination of cytostatic drugs in Besòs river (NE Spain) and comparison with predicted environmental concentrations. Environ Sci Pollut Res2017; 24: 6492–6503.
49.
KosjekTPerkoSŽigonD,et al.Fluorouracil in the environment: analysis, occurrence, degradation and transformation. J Chromatogr A 2013; 1290: 62–72.
50.
Ferre-AracilJValcárcelYNegreiraN, et al.Ozonation of hospital raw wastewaters for cytostatic compounds removal. Kinetic modelling and economic assessment of the process. Sci Total Environ2016; 556: 70–79.
51.
Garcia-CostaALGouveiaTIAPereiraMFR, et al.Intensification strategies for cytostatics degradation by ozone-based processes in aqueous phase. J Hazard Mater2022; 440: 129743.
52.
González-BurciagaLANúñez-NúñezCMProal-NájeraJB. Challenges of TiO2 heterogeneous photocatalysis on cytostatic compounds degradation: state of the art. Environ Sci Pollut Res2022; 29: 42251–42274.
